Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Scandinavian Journal of Clinical and Laboratory Investigation|March 10, 2017
Circulating androgens and SHBG during the normal menstrual cycle in two ethnic populationsTaraneh Rezaii, Thomas P Gustafsson, Magnus Axelson, et al.
Acta Ophthalmologica|November 27, 2008
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cellsAda Girnita, Charlotta All-Ericsson, Mario A Economou, et al.
Fertility and Sterility|February 9, 2010
Selective insulin-like growth factor-I antagonist inhibits mouse embryo development in a dose-dependent mannerJose Inzunza, Olle Danielsson, Parameswaran Grace Lalitkumar, et al.
Hepatology (Baltimore, Md.)|September 27, 2003
Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitorEwa Ellis, Magnus Axelson, Anna Abrahamsson, et al.
Medical Oncology (Northwood, London, England)|May 30, 2015
Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cellsThomas Strömberg, Xiaoying Feng, Maryam Delforoush, et al.
Investigative Ophthalmology & Visual Science|June 3, 2008
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanomaMario A Economou, Sandra Andersson, Diana Vasilcanu, et al.
Acta Ophthalmologica|November 27, 2008
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanomaMario A Economou, Sandra Andersson, Diana Vasilcanu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Expression and growth dependency of the insulin-like growth factor I receptor in craniopharyngioma cells: a novel therapeutic approachElfar Ulfarsson, Alexandra Karström, Shucheng Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-ISergiu-Bogdan Catrina, Ileana Ruxandra Botusan, Anja Rantanen, et al.
Journal of Hematology & Oncology|July 26, 2019
Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK+ T-cell lymphomaBhawana George, Suraj Konnath George, Wenyu Shi, et al.
Pageof 5